Ratnamani Metals & Tubes
- P/E
- 39.67
Key Fundamentals
SmallcapIndustrial ProductsCapital GoodsPrice-based figures as of · EPS basis: Consolidated · TTM
- ROCE
- 17.90%
- Debt to Equity
- 0.08
- EPS (TTM)
- ₹61.75
- Book Value
- ₹586.46
- Market Cap
- —
- P/E (TTM)
- 39.67
- P/B
- 4.18
- ROE
- 12.60%
- Dividend Yield
- 0.42%
- EBITDA
- ₹880 Cr
- 52W High
- ₹3,345.00
- 52W Low
- ₹1,936.50
- Day Range
- ₹2,360.00 – ₹2,471.50
- Volume
- 17,308
Peer Comparison
Industrials › Industrial Products › Iron & Steel Products
| ₹2,400.00 | 27.41 | ₹60,980 Cr | 5.96 | 0.22% | 19.40% | 22.90% | ₹17,300 Cr | ₹2,319 Cr | |
| ₹2,199.80 | 49.69 | ₹60,246 Cr | 10.64 | 0.39% | 25.40% | 31.80% | ₹23,065 Cr | ₹1,229 Cr | |
| ₹1,231.40 | 30.60 | ₹34,478 Cr | 2.78 | 0.15% | 9.70% | 13.00% | ₹19,584 Cr | ₹1,121 Cr | |
| ₹2,449.40 | 39.67 | ₹17,025 Cr | 4.18 | 0.42% | 12.60% | 17.90% | ₹4,314 Cr | ₹514 Cr | |
| ₹253.22 | 29.51 | ₹15,754 Cr | 1.28 | 0.81% | 8.20% | 10.40% | ₹18,501 Cr | ₹498 Cr | |
| ₹486.00 | 29.21 | ₹14,245 Cr | 4.49 | 0.81% | 15.10% | 19.50% | ₹3,837 Cr | ₹508 Cr | |
| ₹529.15 | 29.28 | ₹12,939 Cr | 3.66 | 0.38% | 15.60% | 18.20% | ₹4,437 Cr | ₹436 Cr | |
| Median 7 companies | ₹1,231.40 | 29.51 | ₹17,025 Cr | 4.18 | 0.39% | 15.10% | 18.20% | ₹17,300 Cr | ₹514 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the latest price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100, as of . How it works →
Overall score
Data confidence 100/100
Category scores
- Quality
- 75
- Strong
- Returns, margins, earnings quality 22% weight
- Valuation
- 56
- Good
- Cheap vs sector & own history 24% weight
- Growth
- 6
- Poor
- Sales & profit trajectory 9% weight
- Financial Health
- 76
- Strong
- Solvency, leverage, coverage 9% weight
- Momentum
- 29
- Poor
- Trend strength, vol-adjusted 12% weight
- Ownership
- 49
- Average
- FII/DII/promoter flows 24% weight
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Strengths
1- Company is almost debt free.
No weaknesses listed
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Bearish | 8 | 6 | 5 |
| Oscillators | Bearish | 2 | 6 | 1 |
| Moving Averages | Strong Bearish | 6 | 0 | 4 |
Oscillators
Bearish
Overall
Bearish
Moving Averages
Strong Bearish
Key readings
- RSI (14)
- 47.96
- Neutral
- MACD (12,26,9)
- −65.27
- Bullish
- SMA (50)
- 2,606.41
- Bearish
- SMA (200)
- 2,467.18
- Bearish
As of
Analyst Rating
5 of 6 analysts rate Buy, 1 Hold, 0 Sell.
As of
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | +10.09% |
|---|---|
| 5Y | +14.36% |
| 3Y | +0.15% |
| 1Y | −13.34% |
| TTM | −16.28% |
Net profit
| 10Y | +12.46% |
|---|---|
| 5Y | +14.11% |
| 3Y | +1.41% |
| 1Y | −1.48% |
| TTM | −8.54% |
Operating cash flow
| 10Y | +19.70% |
|---|---|
| 5Y | +11.38% |
| 3Y | +44.53% |
| 1Y | +74.63% |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | +0.16 pp |
|---|---|
| 5Y | −0.54 pp |
| 3Y | −0.47 pp |
| 1Y | +0.98 pp |
| TTM | +0.51 pp |
Revenue by year
| Mar 2017 | ₹1,412 Cr |
|---|---|
| Mar 2018 | ₹1,767 Cr |
| Mar 2019 | ₹2,755 Cr |
| Mar 2020 | ₹2,586 Cr |
| Mar 2021 | ₹2,298 Cr |
| Mar 2022 | ₹3,139 Cr |
| Mar 2023 | ₹4,474 Cr |
| Mar 2024 | ₹5,059 Cr |
| Mar 2025 | ₹5,186 Cr |
| Mar 2026 | ₹4,494 Cr |
Net profit by year
| Mar 2017 | ₹144 Cr |
|---|---|
| Mar 2018 | ₹152 Cr |
| Mar 2019 | ₹253 Cr |
| Mar 2020 | ₹308 Cr |
| Mar 2021 | ₹276 Cr |
| Mar 2022 | ₹323 Cr |
| Mar 2023 | ₹512 Cr |
| Mar 2024 | ₹625 Cr |
| Mar 2025 | ₹542 Cr |
| Mar 2026 | ₹534 Cr |
Analyst Forecasts
AI Analysis — Bull vs Bear
Ratnamani Metals & Tubes Ltd trades at ₹2,449.40 as of 2026-11-04 with a market cap of ₹17,025.35 crore and a PE of 39.67x. The company is virtually debt-free with a debt-to-equity ratio of 0.08, but recent growth has turned negative with TTM sales declining 16% and TTM profit declining 23%.
- Near debt-free balance sheet with a debt-to-equity ratio of just 0.08, providing significant financial flexibility and low interest burden.
- Solid long-term compounding track record with 10-year sales CAGR of 10% and 10-year profit CAGR of 11%, demonstrating sustained business growth over a full cycle.
- Healthy 5-year profit CAGR of 12% and 5-year sales CAGR of 14%, indicating strong medium-term revenue and earnings expansion prior to the recent slowdown.
- Consistent return on equity over longer periods — 10-year average ROE of 17% and 5-year average ROE of 17% — reflecting disciplined capital allocation.
- ROCE of 16.32% as of 2026-11-04 remains well above typical cost of capital, suggesting the business continues to generate economic value.
- Stock has corrected roughly 27% from its 52-week high of ₹3,345, which may reflect a degree of mean-reversion risk being priced in.
- 10-year stock CAGR of 19% demonstrates long-term wealth creation for shareholders across market cycles.
- TTM profit has declined 23%, signalling a sharp earnings contraction that may pressure the current PE multiple of 39.67x.
- TTM sales have declined 16%, indicating meaningful top-line weakness and potential demand or pricing headwinds in the industrial products segment.
- PE ratio of 39.67x is elevated, especially against a backdrop of negative TTM earnings growth, implying the stock is priced for a recovery that may not materialise quickly.
- 3-year profit CAGR has turned negative at -1% and 3-year sales CAGR is flat at 0%, suggesting the recent downturn is not merely a one-quarter blip.
- Last-year ROE of 13% and current ROE of 12.7% are noticeably below the 10-year average of 17%, indicating declining return efficiency.
- Price-to-book ratio of 4.18x is relatively high for a capital-goods manufacturer experiencing negative near-term growth.
- Dividend yield of only 0.42% offers minimal income cushion to investors during periods of capital depreciation.
- 3-year stock CAGR of -2% shows the stock has delivered negative returns over a meaningful medium-term horizon, lagging broader market indices.
This is AI-generated analysis, not financial advice. Do your own due diligence.
AI News Digest
TL;DR: Ratnamani presents a mixed picture. The Rs 2700 crore multi-year international order is a strong positive that bolsters long-term revenue visibility and underscores export competitiveness. However, the same-week guidance cut from 20% to 10% on muted domestic demand is a clear near-term concern. The trend is stable but warrants monitoring — execution on the new export backlog will be key to offsetting softer domestic volumes.
- Growth guidance halved to 10% Aug 25
Ratnamani cut FY guidance to 10% from 20% earlier, citing muted demand — a 10 percentage point reduction signaling near-term volume softness.
- Rs 2700 cr international order win Aug 24
Secured a confirmed Rs 2700 crore export order for spool supply from international clients, spanning 2-3 years. Adds significant backlog to a company with strong cash flows, low leverage, and a market cap of Rs 17000 crore.
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,175 | 1,131 | 1,257 | 1,496 | 1,184 | 971 | 1,316 | 1,715 | 1,152 | 1,192 | 1,066 | 1,085 | 972 |
| Expenses | 969 | 886 | 1,057 | 1,250 | 1,020 | 818 | 1,112 | 1,413 | 963 | 980 | 861 | 931 | 809 |
| Operating Profit | 206 | 245 | 200 | 246 | 164 | 154 | 204 | 302 | 188 | 211 | 205 | 154 | 162 |
| OPM % | 18% | 22% | 16% | 16% | 14% | 16% | 15% | 18% | 16% | 18% | 19% | 14% | 17% |
| Other Income | 9 | 11 | 15 | 39 | 12 | 20 | 19 | 9 | 30 | 27 | 13 | 41 | 18 |
| Interest | 10 | 11 | 13 | 12 | 10 | 14 | 7 | 7 | 11 | 7 | 7 | 6 | 6 |
| Depreciation | 24 | 24 | 25 | 25 | 26 | 26 | 27 | 29 | 32 | 32 | 33 | 35 | 36 |
| PBT | 181 | 221 | 178 | 248 | 140 | 134 | 188 | 276 | 176 | 199 | 177 | 154 | 137 |
| Tax % | 25% | 26% | 25% | 22% | 25% | 26% | 29% | 26% | 28% | 22% | 24% | 25% | 22% |
| Net Profit | 135 | 164 | 133 | 193 | 106 | 99 | 133 | 203 | 127 | 156 | 135 | 116 | 107 |
| EPS (₹) | 19.1 | 23.38 | 18.96 | 27.42 | 15 | 14.32 | 18.73 | 29.55 | 18.81 | 19.43 | 15.67 | 14.93 | 11.72 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,688 | 1,718 | 1,412 | 1,767 | 2,755 | 2,586 | 2,298 | 3,139 | 4,474 | 5,059 | 5,186 | 4,494 | 4,314 |
| Expenses | 1,388 | 1,431 | 1,155 | 1,501 | 2,348 | 2,159 | 1,898 | 2,644 | 3,699 | 4,162 | 4,363 | 3,736 | 3,582 |
| Operating Profit | 300 | 287 | 257 | 266 | 407 | 427 | 400 | 495 | 776 | 897 | 824 | 758 | 732 |
| OPM % | 18% | 17% | 18% | 15% | 15% | 16% | 17% | 16% | 17% | 18% | 16% | 17% | 17% |
| Other Income | 26 | 16 | 14 | 32 | 41 | 59 | 43 | 38 | 32 | 73 | 60 | 112 | 99 |
| Interest | 9 | 6 | 6 | 10 | 15 | 21 | 23 | 21 | 31 | 45 | 37 | 31 | 27 |
| Depreciation | 54 | 57 | 60 | 61 | 62 | 59 | 57 | 80 | 83 | 98 | 108 | 132 | 136 |
| PBT | 262 | 240 | 205 | 228 | 371 | 406 | 363 | 431 | 694 | 828 | 738 | 706 | 668 |
| Tax % | 34% | 31% | 30% | 33% | 32% | 24% | 24% | 25% | 26% | 24% | 27% | 24% | — |
| Net Profit | 173 | 165 | 144 | 152 | 253 | 308 | 276 | 323 | 512 | 625 | 542 | 534 | 514 |
| EPS (₹) | 24.74 | 23.58 | 20.55 | 21.65 | 36.08 | 43.87 | 39.37 | 46.03 | 72.83 | 88.85 | 77.61 | 68.85 | 61.75 |
| Div. Payout % | 15% | 16% | 18% | 18% | 17% | 18% | 24% | 20% | 16% | 16% | 18% | 15% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 14 | 14 | 14 | 14 |
| Reserves | 900 | 1,036 | 1,178 | 1,299 | 1,513 | 1,700 | 1,978 | 2,239 | 2,590 | 3,127 | 3,623 | 4,097 |
| Borrowings | 39 | 23 | 0 | 79 | 65 | 252 | 207 | 157 | 237 | 153 | 157 | 318 |
| Other Liabilities | 279 | 250 | 226 | 360 | 465 | 584 | 422 | 557 | 939 | 726 | 1,108 | 957 |
| Total Liabilities | 1,227 | 1,319 | 1,414 | 1,747 | 2,053 | 2,545 | 2,617 | 2,962 | 3,780 | 4,020 | 4,903 | 5,385 |
| Fixed Assets | 425 | 446 | 448 | 445 | 440 | 500 | 865 | 875 | 1,122 | 1,164 | 1,348 | 1,611 |
| CWIP | 42 | 48 | 38 | 47 | 179 | 371 | 76 | 107 | 101 | 167 | 190 | 302 |
| Investments | 20 | 24 | 74 | 0 | 203 | 155 | 637 | 109 | 135 | 89 | 180 | 644 |
| Other Assets | 740 | 801 | 854 | 1,255 | 1,231 | 1,518 | 1,039 | 1,873 | 2,422 | 2,601 | 3,185 | 2,828 |
| Total Assets | 1,227 | 1,319 | 1,414 | 1,747 | 2,053 | 2,545 | 2,617 | 2,962 | 3,780 | 4,020 | 4,903 | 5,385 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 148 | 155 | 134 | −73 | 554 | 215 | 546 | −283 | 310 | 511 | 536 | 936 |
| Investing | −52 | −11 | −104 | 21 | −360 | −358 | −470 | 418 | −204 | −146 | −388 | −1,147 |
| Financing | −74 | −179 | −28 | 42 | −56 | 47 | −79 | −135 | −116 | −193 | −130 | 59 |
| Net Cash Flow | 23 | −35 | 3 | −10 | 137 | −96 | −3 | 0 | −10 | 173 | 18 | −151 |
| Free Cash Flow | 65 | 94 | 69 | −142 | 389 | −83 | 417 | −427 | 173 | 302 | 230 | 452 |
| CFO/EBITDA | 78 | 77 | 81 | 0 | 170 | 75 | 151 | −33 | 59 | 82 | 87 | 147 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 48 | 83 | 110 | 115 | 61 | 52 | 64 | 70 | 82 | 68 | 89 | 82 |
| Inventory Days | 112 | 95 | 141 | 184 | 113 | 185 | 133 | 193 | 156 | 148 | 163 | 174 |
| Days Payable | 41 | 40 | 48 | 62 | 56 | 57 | 60 | 55 | 46 | 39 | 42 | 46 |
| Cash Conversion Cycle | 119 | 138 | 202 | 237 | 118 | 180 | 137 | 208 | 192 | 177 | 210 | 210 |
| Working Capital Days | 81 | 118 | 167 | 173 | 78 | 98 | 85 | 145 | 123 | 128 | 134 | 148 |
| ROCE % | — | 25% | 19% | 18% | 26% | 24% | 19% | 20% | 27% | 28% | 22% | 18% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Ratnamani Metals & Tubes insights
63 extracted metrics across FY10–FY27.
Documents
- Q1 FY27 concall · Aug 2026PPT
- Q4 FY26 concall · May 2026Transcript PPT Recording
- Q3 FY26 concall · Feb 2026PPT
- Q2 FY26 concall · Nov 2025Transcript PPT Recording
- Q4 FY25 concall · May 2025Transcript Recording
- 9 Sep 2026
- 11 Jun 2025
- 15 Mar 2024
- 6 Jan 2023
- 14 Oct 2021
- General announcements 30 Oct 2026
Frequently Asked Questions about Ratnamani Metals & Tubes
What does Ratnamani Metals & Tubes Ltd do?
Where is Ratnamani Metals & Tubes Ltd (RATNAMANI) listed?
Which sector does Ratnamani Metals & Tubes Ltd belong to?
What is the PE ratio of Ratnamani Metals & Tubes Ltd?
What is the 52-week high and low of Ratnamani Metals & Tubes Ltd?
Does Ratnamani Metals & Tubes Ltd pay dividends?
What is the Return on Equity (ROE) of Ratnamani Metals & Tubes Ltd?
Company Information
Ratnamani Metals & Tubes Ltd is engaged in the manufacturing of stainless steel pipes and tubes and carbon steel pipes from its manufacturing facilities in India.
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/RATNAMANI.md for Ratnamani Metals & Tubes Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.